Copyright
©The Author(s) 2026.
World J Gastroenterol. Feb 21, 2026; 32(7): 114538
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.114538
Published online Feb 21, 2026. doi: 10.3748/wjg.v32.i7.114538
Figure 1 Multilayered diagram showing the progression from adenoma to colorectal cancer, current blood-based biomarker discovery approaches, and future diagnostic directions.
dPCR: Digital polymerase chain reaction; LC-MS: Liquid chromatography-mass spectrometry; UHPLC-MS: Ultra-high performance liquid chromatography-mass spectrometry; CRC: Colorectal cancer; NAA: Non-advanced adenomas; AA: Advanced adenomas; 10-yr Cum Inc: 10-year cumulative incidence.
- Citation: Qi CY, Wang R, Wang JW, Ye GL, Yang P, Zhou YP. Noninvasive diagnosis of colorectal adenoma: The emerging potential of blood-based biomarkers. World J Gastroenterol 2026; 32(7): 114538
- URL: https://www.wjgnet.com/1007-9327/full/v32/i7/114538.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i7.114538
